AbCellera to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022

Rhea-AI Summary

AbCellera (Nasdaq: ABCL) has announced its participation in the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022, in Toronto, Canada. The presentation will commence at 6:30 a.m. PT (9:30 a.m. ET). A live audio webcast will be available on AbCellera's Investor Relations website, with a replay accessible post-event. AbCellera specializes in leveraging immune system analysis to discover antibodies that can be developed into therapeutic drugs, collaborating with various drug developers to enhance drug development efficiency.

VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on Monday, May 2, 2022, in Toronto, Canada at 6:30 a.m. Pacific Time (9:30 a.m. Eastern Time).

A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005146/en/

Inquiries

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774

Business Development: Neil Berkley; bd@abcellera.com, +1(604)559-9005

Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116

Source: AbCellera Biologics Inc.

FAQ

When is AbCellera presenting at the Bloom Burton & Co. Healthcare Investor Conference?

AbCellera will present on May 2, 2022, at 6:30 a.m. PT (9:30 a.m. ET).

Where is the Bloom Burton & Co. Healthcare Investor Conference being held?

The conference is taking place in Toronto, Canada.

How can I access the AbCellera presentation?

The live audio webcast of the presentation can be accessed through AbCellera's Investor Relations website.

What is the focus of AbCellera's business?

AbCellera focuses on finding antibodies for drug development by analyzing natural immune systems.

What is the ticker symbol for AbCellera?

The ticker symbol for AbCellera is ABCL.